Home Cart Sign in  
Chemical Structure| 198470-84-7 Chemical Structure| 198470-84-7

Structure of Parecoxib
CAS No.: 198470-84-7

Chemical Structure| 198470-84-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Parecoxib is a potent and selective COX2 inhibitor.

Synonyms: Vorth-P; Valus-P; SC 69124

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Parecoxib

CAS No. :198470-84-7
Formula : C19H18N2O4S
M.W : 370.42
SMILES Code : CCC(NS(=O)(C1=CC=C(C2=C(C)ON=C2C3=CC=CC=C3)C=C1)=O)=O
Synonyms :
Vorth-P; Valus-P; SC 69124
MDL No. :MFCD25976408
InChI Key :TZRHLKRLEZJVIJ-UHFFFAOYSA-N
Pubchem ID :119828

Safety of Parecoxib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • COX-2

In Vitro:

Cell Line
Concentration Treated Time Description References
AC2F rat liver cells 5, 10, 20, 40, 80 µM 12 hours or 48 hours To evaluate the cytotoxicity of parecoxib to Ac2F cells Biomol Ther (Seoul). 2021 Sep 1;29(5):519-526
Human colorectal cancer DLD-1 cells 3 µM 48 hours Parecoxib enhances resveratrol's ability to inhibit DLD-1 cell viability and increases apoptosis by inhibiting TXNDC5 and Akt phosphorylation. Nutrients. 2024 Sep 6;16(17):3020
SW480 cells 3 µM 48 hours To evaluate the inhibitory effect of parecoxib combined with 5-FU on the migration and invasion of SW480 cells. The results showed that the combination of parecoxib and 5-FU significantly inhibited cell migration and invasion. Biomedicines. 2024 Jul 9;12(7):1526
DLD-1 cells 3 µM 48 hours To evaluate the inhibitory effect of parecoxib combined with 5-FU on the migration and invasion of DLD-1 cells. The results showed that the combination of parecoxib and 5-FU significantly inhibited cell migration and invasion. Biomedicines. 2024 Jul 9;12(7):1526
3T3-L1 murine preadipocytes 15, 30, 60 µM 8 days To evaluate the effect of parecoxib on adipocyte differentiation Biomol Ther (Seoul). 2021 Sep 1;29(5):519-526

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Sprague-Dawley rats Pulmonary ischemia-reperfusion injury model Intraperitoneal injection 10 mg/kg Once daily for 5 consecutive days Parecoxib sodium pretreatment alleviates pulmonary ischemia-reperfusion injury by inhibiting the ERK/NF-κB pathway and further activating the HIF-1α pathway. Immun Inflamm Dis. 2022 Sep;10(9):e684
Sprague-Dawley rats Ischemia reperfusion-induced intestinal injury model Intraperitoneal injection 10 or 20 mg/kg Once daily for 5 consecutive days Parecoxib sodium pre-treatment significantly attenuated ischemia reperfusion-induced oxidative stress, inflammatory responses, and apoptosis, and increased the survival rate of rats. Mol Med Rep. 2021 Nov;24(5):776

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT06600282 Post-operative Pain|Bioequival... More >>ence Study in Healthy Subjects Less << PHASE4 NOT_YET_RECRUITING 2024-12-30 Taichung Veterans General Hosp... More >>ital, Taichung, 40705, Taiwan Less <<
NCT01221025 Emergence Delirium|Postoperati... More >>ve Pain Less << PHASE4 UNKNOWN 2025-06-12 The First Affiliated Hospital ... More >>of Sun Yat-sen University, Guangzhou, Guangdong, 510080, China Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.70mL

0.54mL

0.27mL

13.50mL

2.70mL

1.35mL

27.00mL

5.40mL

2.70mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories